A previous study also showed that celecoxib may widely regulate the expression of proteins in HCT-116 cells based on proteomic profiles, and degrade GLI1 by downregulating molecular chaperone activities, activating tumor suppressors and regulating the expression of peroxiredoxin I and creatine kinase, among others (25). This evidence concerns the gene GLI1 and neoplasm.